CRL
Charles River LaboratoriesStockHealthcare$185.00+$2.66 (+1.46%)as of Jun 18, 4:00 PM ET
Key stats
- Market cap
- 9.1B
- Fwd P/E
- 14.8×
- P/S
- 2.3×
- P/B
- 3.1×
- EPS (ttm)
- -$3.71
- EV/EBITDA
- 24.6×
- EV/Sales
- 2.6×
- P/FCF
- 23.3×
- FCF yield
- 4.30%
- Net margin
- -4.59%
- ROE
- -6.28%
- ROA
- -2.39%
- Debt / equity
- 0.55×
- Current ratio
- 1.36
- Beta
- 1.45
- Div yield
- 0.65%
- 52W high
- -19.17%
- Rel volume
- 1.30×
- 30D $ vol
- 154.3M
Performance
1D
+1.46%
1W
-1.63%
1M
+21.37%
3M
+20.88%
YTD
-8.61%
1Y
+27.54%
5Y
-47.46%
Financial statements
Open full CRL financials →Related Healthcare
1MCharles River Laboratories (CRL) trades at $185.00 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes CRL's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CRL financial statements →